---

$1.90

-0.0150 ( -1.30% ) 431.6K

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

Analyst Insights

---

You need to login to view this content.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-06-28	Sale	-238965.00	Pinto Joshua
2024-06-14	Sale	-20100.00	Ho Maykin
2024-06-14	Sale	-20100.00	Burow Kristina
2024-06-14	Sale	-20100.00	Piacquad David
2024-06-14	Sale	-20100.00	Halawa Alaa
2024-06-14	Sale	-20100.00	Fust Matthew K
2024-04-24	Sale	-114703.00	Aurora Daljit Singh
2024-02-16	Sale	-50000.00	Lenz Robert A.
2024-02-16	Sale	-97500.00	Aurora Daljit Singh
2024-02-16	Sale	-80000.00	Gosebruch Henry O

Reset

Symbol	Issuer Name	Market Value ↓	Share Quantity
No records found.